New Consultation: Formulary decisions November 2023

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the draft decisions made by the NENC formulary group at their meeting in November 2023.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Tuesday 2nd January 2024. Take part by visiting the consultations page.


New consultation: 30 day TA for empagliflozin for chronic heart failure

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on implementation of NICE TA929: Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction, as outlined in the consultation document.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for two weeks and closes at 5pm on Thursday 16th November 2023. Take part by visiting the consultations page.


New consultation: 30 day TA for mirikizumab for ulcerative colitis

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on implementation of NICE TA925: Mirikizumab for treating moderately to severely active ulcerative colitis, as outlined in the consultation document.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for two weeks and closes at 5pm on Wednesday 8th November 2023. Take part by visiting the consultations page.


New consultation: 30 day TA for bimekizumab for axial spondyloarthritis

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on implementation of NICE TA918: Bimekizumab for treating axial spondyloarthritis, as outlined in the consultation document.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for two weeks and closes at 5pm on Wednesday 25th October 2023. Take part by visiting the consultations page.


New consultation: 30 day TA for bimekizumab for psoriatic arthritis

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on implementation of NICE TA916: Bimekizumab for treating active psoriatic arthritis, as outlined in the consultation document.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for two weeks and closes at 5pm on Wednesday 18th October 2023. Take part by visiting the consultations page.


New Consultation: Formulary Amendments August 2023

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the proposed formulary amendments in a new consultation, covering NICE Technology Appraisals and other relevant guidance and alerts published in August 2023.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Tuesday 10th October 2023. Take part by visiting the consultations page.


New Consultation: Formulary Amendments July 2023

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the proposed formulary amendments in a new consultation.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Wednesday 6th September 2023. Take part by visiting the consultations page.


New consultation: NENC formulary decisions

The North East and North Cumbria (NENC) Medicines Committee are seeking system-wide views on adoption of the draft decisions made by the NENC formulary group at their meeting in July 2023.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

The consultation is open until 5pm on Tuesday 22nd August 2023 and can be accessed on the consultations page.


New Consultation: Formulary Amendments June 2023

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the proposed formulary amendments in a new consultation.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Monday 7th August 2023. Take part by visiting the consultations page.


New consultations: penicillin allergy and lipid guidelines

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of two draft guidelines:

  • Northern England Evaluation and Lipid Intensification guideline
  • NENC Penicillin Allergy Assessment Primary Care guideline

Comments are welcomed from across the system, including residents and patients of the NENC.

Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

The consultations are open until 5pm on Wednesday 2nd August 2023 and can be accessed at https://ntag.nhs.uk/consultations/.